Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 4Melanoma 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Smoking Cessation 1Nose Neoplasms 1Neoplasms 1Multiple Pulmonary Nodules 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Liver Cirrhosis 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Endometrial Neoplasms 1Cancer Diagnosis 1Burkitt Lymphoma 1Biliary Tract Neoplasms 1

Interventions

Gemcitabine 83Cisplatin 59pembrolizumab 29Paclitaxel 21Nivolumab 21Carboplatin 21Cystectomy 20Docetaxel 18durvalumab 17atezolizumab 17Magnetic Resonance Spectroscopy 16Specimen Handling 15Radiotherapy 14avelumab 13Mitomycin 13Sunitinib 12Doxorubicin 12Methotrexate 11Fluorouracil 11Vinblastine 10Filgrastim 7BCG Vaccine 7enfortumab vedotin 6Sorafenib 6Ipilimumab 6Immunoglobulin G 6Disulfides 6Biopsy 6cabozantinib 5Trastuzumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Urinary Bladder Neoplasms × Positron-Emission Tomography × Clear all
NCT02805608 2018-04-11

uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer

Rigshospitalet, Denmark

Phase 2 Unknown
40 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡